Serotonin transporter antagonists target tumor-initiating cells in a transgenic mouse model of breast cancer.
about
Serotonergic system antagonists target breast tumor initiating cells and synergize with chemotherapy to shrink human breast tumor xenografts.Oridonin synergistically enhances JQ1-triggered apoptosis in hepatocellular cancer cells through mitochondrial pathway.Targeting TCTP with Sertraline and Thioridazine in Cancer Treatment.
P2860
Serotonin transporter antagonists target tumor-initiating cells in a transgenic mouse model of breast cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 July 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Serotonin transporter antagoni ...... mouse model of breast cancer.
@en
Serotonin transporter antagoni ...... mouse model of breast cancer.
@nl
type
label
Serotonin transporter antagoni ...... mouse model of breast cancer.
@en
Serotonin transporter antagoni ...... mouse model of breast cancer.
@nl
prefLabel
Serotonin transporter antagoni ...... mouse model of breast cancer.
@en
Serotonin transporter antagoni ...... mouse model of breast cancer.
@nl
P2093
P2860
P356
P1433
P1476
Serotonin transporter antagoni ...... mouse model of breast cancer.
@en
P2093
Adele Girgis-Gabardo
Andrew O Giacomelli
Anna Dvorkin-Gheva
Jennifer N P Bisson
Jeremy E Jensen
John A Hassell
Robin M Hallett
William D Gwynne
P2860
P304
53137-53152
P356
10.18632/ONCOTARGET.10614
P407
P577
2016-07-15T00:00:00Z